2016 Form 10-K Financial Statement

#000150237716000031 Filed on August 25, 2016

View on sec.gov

Income Statement

Concept 2016 2015 Q2 2015
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $1.220M $280.0K $2.561M
YoY Change -52.35% -39.13% 16.39%
% of Gross Profit
Research & Development $0.00 $10.00K $363.5K
YoY Change -100.0% -96.15% -94.81%
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $1.220M $290.0K $2.924M
YoY Change -58.27% -60.27% -68.22%
Operating Profit
YoY Change
Interest Expense $0.00 -$1.270M -$1.434M
YoY Change -100.0% 0.27%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$1.220M -$1.560M -$3.608M
YoY Change -66.18% 113.7% -60.78%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$1.220M -$1.560M -$3.608M
YoY Change -66.18% 113.7% -60.78%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$310.6K -$402.1K -$938.9K
COMMON SHARES
Basic Shares Outstanding 3.876M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2016 2015 Q2 2015
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.254M $1.950M $1.947M
YoY Change -35.57% -43.48% -43.56%
Cash & Equivalents $1.947M
Short-Term Investments
Other Short-Term Assets $58.17K $70.00K $67.38K
YoY Change -13.67% -30.0% -32.62%
Inventory
Prepaid Expenses $67.38K
Receivables
Other Receivables
Total Short-Term Assets $1.313M $2.014M $2.014M
YoY Change -34.84% -43.21% -43.26%
LONG-TERM ASSETS
Property, Plant & Equipment $0.00 $0.00
YoY Change -100.0% -100.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $0.00 $0.00 $0.00
YoY Change
Other Assets $0.00 $0.00
YoY Change -100.0% -100.0%
Total Long-Term Assets $0.00 $0.00 $0.00
YoY Change -100.0% -100.0%
TOTAL ASSETS
Total Short-Term Assets $1.313M $2.014M $2.014M
Total Long-Term Assets $0.00 $0.00 $0.00
Total Assets $1.313M $2.014M $2.014M
YoY Change -34.84% -59.56% -59.55%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $20.85K $24.88K $24.88K
YoY Change -16.2% -82.25% -82.23%
Accrued Expenses $92.88K $78.10K $78.10K
YoY Change 18.92% 67.97% 56.2%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $113.7K $103.0K $103.0K
YoY Change 10.45% -44.82% -45.8%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $113.7K $103.0K $103.0K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $113.7K $100.0K $103.0K
YoY Change 10.45% -47.37% -45.8%
SHAREHOLDERS EQUITY
Retained Earnings -$31.06M
YoY Change 13.14%
Common Stock $32.97M
YoY Change 2.25%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.199M $1.911M $1.911M
YoY Change
Total Liabilities & Shareholders Equity $1.313M $2.014M $2.014M
YoY Change -34.84% -59.56% -59.55%

Cashflow Statement

Concept 2016 2015 Q2 2015
OPERATING ACTIVITIES
Net Income -$1.220M -$1.560M -$3.608M
YoY Change -66.18% 113.7% -60.78%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$692.6K -$110.0K -$1.501M
YoY Change -53.87% -77.55% -84.33%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00
YoY Change
Cash From Investing Activities $0.00 $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 5.080M 0.000 $0.00
YoY Change
NET CHANGE
Cash From Operating Activities -$692.6K -110.0K -$1.501M
Cash From Investing Activities 0.000 $0.00
Cash From Financing Activities 5.080M 0.000 $0.00
Net Change In Cash -$692.6K -110.0K -$1.501M
YoY Change -53.87% -77.55% -84.33%
FREE CASH FLOW
Cash From Operating Activities -$692.6K -$110.0K -$1.501M
Capital Expenditures $0.00 $0.00
Free Cash Flow -$110.0K -$1.501M
YoY Change -77.55% -84.33%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2015Q1 ctgo Additionaleconomicinterestsellable
ADDITIONALECONOMICINTERESTSELLABLE
0.20
CY2015 ctgo Acquisition Costs Mining Properties Period Cost
AcquisitionCostsMiningPropertiesPeriodCost
0 USD
CY2016 ctgo Acquisition Costs Mining Properties Period Cost
AcquisitionCostsMiningPropertiesPeriodCost
0 USD
CY2012Q3 ctgo Acreageof Unpatented Mining Claims Alaska
AcreageofUnpatentedMiningClaimsAlaska
71896 acre
CY2015Q2 ctgo Contangospercentageofinterestin Joint Venture Company
ContangospercentageofinterestinJointVentureCompany
1.00
CY2016Q2 ctgo Contangospercentageofinterestin Joint Venture Company
ContangospercentageofinterestinJointVentureCompany
0.89
CY2015 ctgo Costs Of Unproved Properties Excluded From Amortization Mining Properties Period Cost
CostsOfUnprovedPropertiesExcludedFromAmortizationMiningPropertiesPeriodCost
492600 USD
CY2016 ctgo Costs Of Unproved Properties Excluded From Amortization Mining Properties Period Cost
CostsOfUnprovedPropertiesExcludedFromAmortizationMiningPropertiesPeriodCost
14425 USD
CY2015 ctgo Deferred Stateand Local Tax Netof Valuation Allowance
DeferredStateandLocalTaxNetofValuationAllowance
0 USD
CY2016 ctgo Deferred Stateand Local Tax Netof Valuation Allowance
DeferredStateandLocalTaxNetofValuationAllowance
0 USD
CY2015Q2 ctgo Deferred Tax Assets Capitalized Exploration
DeferredTaxAssetsCapitalizedExploration
8490624 USD
CY2016Q2 ctgo Deferred Tax Assets Capitalized Exploration
DeferredTaxAssetsCapitalizedExploration
8699117 USD
CY2015 ctgo Expensereimbursement
Expensereimbursement
750000 USD
CY2016 ctgo Expensereimbursement
Expensereimbursement
USD
CY2015 ctgo Exploration Costs And Claim Rentals Mining Properties Period Cost
ExplorationCostsAndClaimRentalsMiningPropertiesPeriodCost
492600 USD
CY2016 ctgo Exploration Costs And Claim Rentals Mining Properties Period Cost
ExplorationCostsAndClaimRentalsMiningPropertiesPeriodCost
14425 USD
ctgo Explorationexpenseofequitymethodinvestment
Explorationexpenseofequitymethodinvestment
1818318 USD
ctgo Explorationexpenseofequitymethodinvestment
Explorationexpenseofequitymethodinvestment
9531859 USD
CY2016 ctgo Explorationexpenseofequitymethodinvestment
Explorationexpenseofequitymethodinvestment
7713541 USD
ctgo Generaland Administrative Expenseof Equity Method Investment
GeneralandAdministrativeExpenseofEquityMethodInvestment
484964 USD
ctgo Generaland Administrative Expenseof Equity Method Investment
GeneralandAdministrativeExpenseofEquityMethodInvestment
1802399 USD
CY2016 ctgo Generaland Administrative Expenseof Equity Method Investment
GeneralandAdministrativeExpenseofEquityMethodInvestment
1317435 USD
ctgo Investmentby Joint Venture Partner
InvestmentbyJointVenturePartner
10700000 USD
CY2016 ctgo Investmentby Joint Venture Partner
InvestmentbyJointVenturePartner
5650000 USD
CY2015Q1 ctgo Jointadventureeconomicinterest
Jointadventureeconomicinterest
0.40
CY2015Q1 ctgo Jointadventureinterestretainedinthe Company
JointadventureinterestretainedintheCompany
0.60
CY2015Q1 ctgo Jointadventureinvestment
Jointadventureinvestment
45700000 USD
CY2015Q2 ctgo Options And Warrants Outstanding
OptionsAndWarrantsOutstanding
1675999 shares
CY2012Q4 ctgo Rate Of Rights Distribution
RateOfRightsDistribution
1
CY2015Q1 ctgo Restrictedstockissuedshares
Restrictedstockissuedshares
10000 shares
CY2015Q1 ctgo Restrictedstockissuedshares Directors
RestrictedstockissuedsharesDIRECTORS
30000 shares
CY2016Q2 ctgo Royal Alaska Joint Venture Percentage
RoyalAlaskaJointVenturePercentage
0.110 Rate
CY2015Q1 ctgo Royal Goldaggregateamountofinvestment
RoyalGoldaggregateamountofinvestment
30000000 USD
CY2015Q1 ctgo Royal Goldinitialinvestment
RoyalGoldinitialinvestment
5000000 USD
ctgo Royalgoldjointventure
Royalgoldjointventure
30000000 USD
CY2015 ctgo Share Based Compensation Expense
ShareBasedCompensationExpense
483080 USD
CY2016 ctgo Share Based Compensation Expense
ShareBasedCompensationExpense
507684 USD
ctgo Suspended Losses
SuspendedLosses
900000 USD
ctgo Suspended Losses
SuspendedLosses
9500000 USD
ctgo Total Expensesof Equity Method Investment
TotalExpensesofEquityMethodInvestment
2303282 USD
ctgo Total Expensesof Equity Method Investment
TotalExpensesofEquityMethodInvestment
11334258 USD
CY2016 ctgo Total Expensesof Equity Method Investment
TotalExpensesofEquityMethodInvestment
9030976 USD
CY2016 dei Amendment Flag
AmendmentFlag
false
CY2015Q1 ctgo Contango Joint Venture Percentage
ContangoJointVenturePercentage
1.00
CY2016 ctgo Numberofsharespreferentialrightwillallowholdertopurchase
Numberofsharespreferentialrightwillallowholdertopurchase
1/100
CY2015Q1 ctgo Royal Goldpercentageofinterest
RoyalGoldpercentageofinterest
0.00
CY2015Q1 ctgo Royalgoldadditionalinvestment
Royalgoldadditionalinvestment
750000 USD
CY2016 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
CY2016 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q4
CY2016 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2016
CY2012Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
80
CY2016 dei Document Period End Date
DocumentPeriodEndDate
2016-06-30
CY2016 dei Document Type
DocumentType
10-K
CY2016 dei Entity Central Index Key
EntityCentralIndexKey
0001502377
CY2016Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
3958540 shares
CY2016 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2016 dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
CY2015Q4 dei Entity Public Float
EntityPublicFloat
12539877 USD
CY2016 dei Entity Registrant Name
EntityRegistrantName
Contango ORE, Inc.
CY2016 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2016 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2015Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
24876 USD
CY2016Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
20854 USD
CY2015Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
78104 USD
CY2016Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
92884 USD
CY2015Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
32928038 USD
CY2016Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
33434899 USD
CY2015 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
-707 USD
CY2015 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
724743 USD
CY2015 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
724743 USD
CY2016 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
507684 USD
CY2015Q2 us-gaap Assets
Assets
2014430 USD
CY2016Q2 us-gaap Assets
Assets
1312654 USD
CY2015Q2 us-gaap Assets Current
AssetsCurrent
2014430 USD
CY2016Q2 us-gaap Assets Current
AssetsCurrent
1312654 USD
CY2015 us-gaap Carrying Costs Property And Exploration Rights
CarryingCostsPropertyAndExplorationRights
129139 USD
CY2016 us-gaap Carrying Costs Property And Exploration Rights
CarryingCostsPropertyAndExplorationRights
14425 USD
CY2014Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3448501 USD
CY2015Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1947046 USD
CY2016Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1254489 USD
CY2015 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-1501455 USD
CY2016 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-692557 USD
CY2015Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2016Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2015Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2016Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2015Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
30000000 shares
CY2016Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
30000000 shares
CY2015Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3876206 shares
CY2016Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3958540 shares
CY2015Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3876206 shares
CY2016Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3958540 shares
CY2015Q2 us-gaap Common Stock Value
CommonStockValue
38762 USD
CY2016Q2 us-gaap Common Stock Value
CommonStockValue
39585 USD
CY2015 us-gaap Costs And Expenses
CostsAndExpenses
2174067 USD
CY2016 us-gaap Costs And Expenses
CostsAndExpenses
1220218 USD
us-gaap Equity Method Investment Summarized Financial Information Net Income Loss
EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss
2303282 USD
CY2015 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0 USD
CY2016 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0 USD
CY2015 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
0 USD
CY2016 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
0 USD
CY2015 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
0 USD
CY2016 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
0 USD
CY2015 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-220170 USD
CY2016 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-62241 USD
CY2015Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 USD
CY2016Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 USD
CY2015Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
1773857 USD
CY2016Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
1960389 USD
CY2015Q2 us-gaap Deferred Tax Assets State Taxes
DeferredTaxAssetsStateTaxes
1880745 USD
CY2016Q2 us-gaap Deferred Tax Assets State Taxes
DeferredTaxAssetsStateTaxes
1942992 USD
CY2015Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
509015 USD
CY2016Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
470561 USD
CY2015Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
12654241 USD
CY2016Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
13073059 USD
CY2015 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.94
CY2016 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.31
CY2016Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
0 USD
CY2015Q2 us-gaap Equity Method Investment Summarized Financial Information Assets
EquityMethodInvestmentSummarizedFinancialInformationAssets
6191080 USD
CY2015Q3 us-gaap Equity Method Investment Summarized Financial Information Assets
EquityMethodInvestmentSummarizedFinancialInformationAssets
2424584 USD
CY2015Q2 us-gaap Equity Method Investment Summarized Financial Information Current Assets
EquityMethodInvestmentSummarizedFinancialInformationCurrentAssets
4757194 USD
CY2015Q3 us-gaap Equity Method Investment Summarized Financial Information Current Assets
EquityMethodInvestmentSummarizedFinancialInformationCurrentAssets
990698 USD
CY2015Q2 us-gaap Equity Method Investment Summarized Financial Information Current Liabilities
EquityMethodInvestmentSummarizedFinancialInformationCurrentLiabilities
2060476 USD
CY2015Q3 us-gaap Equity Method Investment Summarized Financial Information Current Liabilities
EquityMethodInvestmentSummarizedFinancialInformationCurrentLiabilities
1674956 USD
CY2015Q2 us-gaap Equity Method Investment Summarized Financial Information Equity
EquityMethodInvestmentSummarizedFinancialInformationEquity
4130604 USD
CY2015Q3 us-gaap Equity Method Investment Summarized Financial Information Equity
EquityMethodInvestmentSummarizedFinancialInformationEquity
749628 USD
CY2015Q2 us-gaap Equity Method Investment Summarized Financial Information Liabilities
EquityMethodInvestmentSummarizedFinancialInformationLiabilities
2060476 USD
CY2015Q3 us-gaap Equity Method Investment Summarized Financial Information Liabilities
EquityMethodInvestmentSummarizedFinancialInformationLiabilities
1674956 USD
CY2015Q2 us-gaap Equity Method Investment Summarized Financial Information Liabilities And Equity
EquityMethodInvestmentSummarizedFinancialInformationLiabilitiesAndEquity
6191080 USD
CY2015Q3 us-gaap Equity Method Investment Summarized Financial Information Liabilities And Equity
EquityMethodInvestmentSummarizedFinancialInformationLiabilitiesAndEquity
2424584 USD
us-gaap Equity Method Investment Summarized Financial Information Net Income Loss
EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss
11334258 USD
CY2016 us-gaap Equity Method Investment Summarized Financial Information Net Income Loss
EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss
9030976 USD
CY2015Q2 us-gaap Equity Method Investment Summarized Financial Information Noncurrent Assets
EquityMethodInvestmentSummarizedFinancialInformationNoncurrentAssets
1433886 USD
CY2015Q3 us-gaap Equity Method Investment Summarized Financial Information Noncurrent Assets
EquityMethodInvestmentSummarizedFinancialInformationNoncurrentAssets
1433886 USD
CY2014Q2 us-gaap Equity Method Investments
EquityMethodInvestments
0 USD
CY2015Q2 us-gaap Equity Method Investments
EquityMethodInvestments
0 USD
CY2016Q2 us-gaap Equity Method Investments
EquityMethodInvestments
0 USD
CY2015 us-gaap Exploration Expense Mining
ExplorationExpenseMining
363461 USD
CY2016 us-gaap Exploration Expense Mining
ExplorationExpenseMining
0 USD
CY2015 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1948387 USD
CY2016 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
698109 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
2300000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
10900000 USD
CY2015 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1433886 USD
CY2015 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1501455 USD
CY2015 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
0 USD
CY2016 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-692557 USD
CY2015 us-gaap Net Income Loss
NetIncomeLoss
-3607953 USD
CY2016 us-gaap Net Income Loss
NetIncomeLoss
-1220218 USD
CY2017 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
55200 USD
CY2016 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
13800 USD
CY2016Q2 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
5600000 USD
CY2016 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
0 USD
CY2015 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2016 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2015 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
1481373 USD
CY2016 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
400000 USD
CY2015 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-1262783 USD
CY2016 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-427076 USD
CY2015 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
1580 USD
CY2016 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
70540 USD
CY2016 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
0 USD
CY2015 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-83653 USD
CY2016 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
10758 USD
CY2015 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-31522 USD
CY2016 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-9219 USD
CY2015Q2 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
1400000 USD
CY2016Q2 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
0 USD
CY2015Q1 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
1400000 USD
CY2015Q1 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
1433886 USD
CY2015Q1 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
1400000 USD
CY2015Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2014430 USD
CY2016Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1312654 USD
CY2015Q2 us-gaap Liabilities Current
LiabilitiesCurrent
102980 USD
CY2016Q2 us-gaap Liabilities Current
LiabilitiesCurrent
113738 USD
CY2016Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
15000000 shares
CY2015Q2 us-gaap Preferred Stock Value Outstanding
PreferredStockValueOutstanding
0 USD
CY2016Q2 us-gaap Preferred Stock Value Outstanding
PreferredStockValueOutstanding
0 USD
CY2015Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
67384 USD
CY2016Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
58165 USD
CY2015 us-gaap Profit Loss
ProfitLoss
-3607953 USD
CY2015Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-31055350 USD
CY2016Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-32275568 USD
CY2010Q4 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
1600000 shares
CY2015 us-gaap Share Based Compensation
ShareBasedCompensation
724743 USD
CY2016 us-gaap Share Based Compensation
ShareBasedCompensation
507684 USD
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
27000 shares
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
0 shares
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
40000 shares
CY2015 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
0.00
CY2016 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
3928327 shares
CY2016 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
12.41
CY2015 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
438000 USD
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
21400 USD
CY2015 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
70667 shares
CY2015 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
707 USD
CY2014Q2 us-gaap Stockholders Equity
StockholdersEquity
4794660 USD
CY2015Q2 us-gaap Stockholders Equity
StockholdersEquity
1911450 USD
CY2016Q2 us-gaap Stockholders Equity
StockholdersEquity
1198916 USD
CY2015 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
3842909 shares
CY2016 us-gaap Basis Of Accounting
BasisOfAccounting
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:18px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Basis of Presentation</font></div><div style="line-height:120%;padding-top:6px;text-align:justify;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The accompanying consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;). </font></div><div style="line-height:120%;padding-top:6px;text-align:justify;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">These consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the discharge of liabilities in the normal course of business for the foreseeable future. Since the Company&#8217;s primary business is now the investment in and management of the Joint Venture Company, it expects that its ongoing cash requirements will only be related to general and administration expenses. Given this, the Company believes that its current cash balances will be sufficient to meet its working capital requirements for the next twelve months.</font></div></div>
CY2016 us-gaap Description Of New Accounting Pronouncements Not Yet Adopted
DescriptionOfNewAccountingPronouncementsNotYetAdopted
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Recently Issued Accounting Pronouncements. </font><font style="font-family:inherit;font-size:10pt;">In March 2016, the Financial Accounting Standards Board (the &#8220;FASB&#8221;) issued Accounting Standards Update No. 2016-09: </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Compensation &#8211; Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting (ASU 2016-09)</font><font style="font-family:inherit;font-size:10pt;">. ASU 2016&#8209;-09 is part of an initiative to reduce complexity in accounting standards. The areas of simplification in ASU 2016&#8209;-09 involve several aspects of accounting for share-based payment transactions, including the income tax consequences, classification of awards as either equity or liabilities, and classification on the statement of cash flows. For public entities, ASU 2016-09 is effective for financial statements issued for fiscal years beginning after December 15, 2016, including interim periods within those fiscal years; early application is permitted. The provisions of this accounting update are not expected to have a material impact on the Company&#8217;s financial position, results of operations or cash flows. </font></div><div style="line-height:120%;text-align:justify;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In November 2015, the FASB issued ASU No. 2015-17: </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Income Taxes (Topic 740): Balance Sheet Classification of Deferred Taxes.</font><font style="font-family:inherit;font-size:10pt;"> ASU No. 2015-17 provides guidance on the presentation of deferred income taxes that requires deferred tax assets and liabilities, along with related valuation allowances, to be classified as non-current on the balance sheet. As a result, each tax jurisdiction will now only have one net non-current deferred tax asset or liability. The new guidance does not change the existing requirement that prohibits offsetting deferred tax liabilities from one jurisdiction against deferred tax assets of another jurisdiction. The new guidance is effective for the Company&#8217;s fiscal year beginning July 1, 2017 and will only result in a change in presentation of these deferred taxes on our consolidated balance sheets. Early adoption is permitted, and we are currently evaluating the impact of this guidance on our consolidated financial statement</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The FASB has issued ASU No. 2015-02, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Consolidation (Topic 810): Amendments to the Consolidation Analysis</font><font style="font-family:inherit;font-size:10pt;">, which is intended to improve targeted areas of consolidation guidance for legal entities such as limited partnerships, limited liability corporations, and securitization structures (collateralized debt obligations, collateralized loan obligations, and mortgage-backed security transactions). The ASU focuses on the consolidation evaluation for reporting organizations (public and private companies and not-for-profit organizations) that are required to evaluate whether they should consolidate certain legal entities. The ASU will be effective for annual periods beginning after December 15, 2015; and for interim periods, within those fiscal years. Early adoption of this ASU is permitted for financial statements that have not been previously issued.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The FASB has issued ASU No. 2015-01, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Income Statement - Extraordinary and Unusual Items (Subtopic 225-20): Simplifying Income Statement Presentation by Eliminating the Concept of Extraordinary Items.</font><font style="font-family:inherit;font-size:10pt;"> This ASU eliminates from U.S. GAAP the concept of extraordinary items. Subtopic 225-20, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Income Statement - Extraordinary and Unusual Items</font><font style="font-family:inherit;font-size:10pt;">, required that an entity separately classify, present, and disclose extraordinary events and transactions. The amendments in this ASU are effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2015. Early adoption of this ASU is permitted for financial statements that have not been previously issued. </font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company has evaluated all other recent accounting pronouncements and believes that none of them will have a significant effect on the Company's consolidated financial statements.</font></div></div>
CY2012 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:18px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;"></font></div><div style="line-height:120%;padding-top:12px;text-align:justify;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"></font></div></div>
CY2016 us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-align:justify;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Management Estimates.</font><font style="font-family:inherit;font-size:10pt;"> The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</font></div></div>

Files In Submission

Name View Source Status
0001502377-16-000031-index-headers.html Edgar Link pending
0001502377-16-000031-index.html Edgar Link pending
0001502377-16-000031.txt Edgar Link pending
0001502377-16-000031-xbrl.zip Edgar Link pending
a2015ph1ddhwithzones12.jpg Edgar Link pending
a2015ph2ddhwithzones1.jpg Edgar Link pending
a2016phase1explorationprogra.jpg Edgar Link pending
atetlin2016phase2.jpg Edgar Link pending
auditreporta01.jpg Edgar Link pending
ctgo-20160630.xml Edgar Link completed
ctgo-20160630.xsd Edgar Link pending
ctgo-20160630x10k.htm Edgar Link pending
ctgo-20160630x10kxex311.htm Edgar Link pending
ctgo-20160630x10kxex312.htm Edgar Link pending
ctgo-20160630x10kxex321.htm Edgar Link pending
ctgo-20160630x10kxex322.htm Edgar Link pending
ctgo-20160630_cal.xml Edgar Link unprocessable
ctgo-20160630_def.xml Edgar Link unprocessable
ctgo-20160630_lab.xml Edgar Link unprocessable
ctgo-20160630_pre.xml Edgar Link unprocessable
ex231bdo2015opinionconsent.htm Edgar Link pending
ex232-heinconsent.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
fy2016peakgoldauditedfsand.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tetlinmap1082015a01.jpg Edgar Link pending